Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors

被引:13
|
作者
Lobo, JR [1 ]
Nehra, A [1 ]
机构
[1] Mayo Clin, Dept Urol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.ucl.2005.08.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction (ED) is a common disorder that has gained attention since the introduction of relatively safe treatment with phosphodiesterase-5 inhibitors. ED is a multifactorial disorder and a common presentation for several systemic illnesses, particularly vascular occlusive diseases. The clinical evaluation of ED should be thorough and systematic, with attention to the appropriate use of sexual symptom questionnaires and symptom scales, detailed medical and sexual history, physical examination, and basic screening laboratory tests. Patients should be referred for specialized evaluations when appropriate. The clinician must be familiar with the pathophysiologic mechanisms of ED, its associations with other systemic diseases, the indications for specialist referrals, and the role of specialized testing to diagnose and treat this disorder effectively.
引用
收藏
页码:447 / +
页数:10
相关论文
共 50 条
  • [1] Patient preference in clinical practice in treatment of erectile dysfunction with PDE-5 inhibitors
    Stroberg, P.
    Ljunggren, C. R. N.
    Hedelin, H.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 41 - 41
  • [2] EFFICACY OF PDE-5 INHIBITORS IN ERECTILE DYSFUNCTION DUE TO MULTIPLE SCLEROSIS
    Kratiras, Z.
    Konstantinidis, C.
    Thomas, C.
    Panagiotis, K.
    Konstantinos, M.
    Konstantinos, S.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S145 - S146
  • [3] Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction
    Thurtell, M. J.
    Tomsak, R. L.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (06) : 537 - 543
  • [4] Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction
    M J Thurtell
    R L Tomsak
    International Journal of Impotence Research, 2008, 20 : 537 - 543
  • [5] EFFICACY OF PDE-5 INHIBITORS IN ERECTILE DYSFUNCTION AFTER SPINAL CORD INJURY
    Konstantinidis, C.
    Kratiras, Z.
    Alexandros, T.
    Panagiotis, K.
    Thomas, C.
    Konstantinos, S.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S145 - S145
  • [6] PDE-5 inhibitors in treating men with erectile dysfunction and lower urinary tract symptoms
    Gamidov, S.
    Tazhetdinov, O.
    Pavlovichev, A.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 438 - 438
  • [7] CAUSES AND METHODS OF CORRECTION OF PRIMARY RESISTANCE TO ERECTILE DYSFUNCTION THERAPY WITH PDE-5 INHIBITORS
    Rozhivanov, R.
    Kurbatov, D.
    JOURNAL OF MENS HEALTH, 2011, 8 (03) : 211 - 211
  • [8] Clinical experience with PDE-5 inhibitors
    Lema, Luis R.
    INSUFICIENCIA CARDIACA, 2007, 2 (04) : 163 - 167
  • [9] PDE-5 Inhibitors: Clinical Points
    Doumas, Michael
    Lazaridis, Antonios
    Katsiki, Niki
    Athyros, Vasilios
    CURRENT DRUG TARGETS, 2015, 16 (05) : 420 - 426
  • [10] Erectile dysfunction and the role of phosphodiesterase-5 (PDE-5) inhibitors in schizophrenia. A brief review
    Dimopoulos, N. P.
    Mitsonis, C. I.
    EUROPEAN PSYCHIATRY, 2008, 23 : S111 - S112